Bookmark and Share This is AcaDemon.com

Home Sellers Area Buy Term paper FAQs Custom Term Papers Contact Us AcaDemon.com AcaDemon UK AcaDemon Australia AcaDemon Canada AcaDemon France AcaDemon Germany AcaDemon Spain
Tags
aberrant, antagonists, article, cancer, cells, implications, mdm2, mice, nutlin, p53, reveal, review, signaling, therapy, tumors
Currency
Advanced
Article Review # 112794 :: MDM2 and p53 Signaling in Cancer
A review of the article "Small-Molecule MDM2 Antagonists Reveal Aberrant p53 Signaling in Cancer: Implications for Therapy" by Tovar, et al.
Written in 2009; 1,016 words; 3 sources; APA; $ 35.95
Paper Summary:
The paper analyzes the article "Small-Molecule MDM2 Antagonists Reveal Aberrant p53 Signaling in Cancer: Implications for Therapy" and explains the conclusions reached by the authors. The paper is of the opinion that the conclusions may have been slightly optimistic. The paper outlines the method used by the study discussed in the article and notes several limitations of the study.

Outline:
Summary
Method
From the Paper:
"The main focus of the article is around the protein murine double minute 2 (MDM2). MDM2 is a negative regulator of the p53 tumour suppressor protein. This is done through three mechanisms. Firstly, MDM2 binds at the p53 transactivation site and blocks its activation of transcription initiation [1]. Secondly, it participates in the nuclear export of p53 [1]. Thirdly, it serves as a ubiquitin ligase, promoting the degradation of p53. When p53 is activated, it can bring a halt upon the cell cycle and cause apoptosis [1]. This is very important as p53 acts as a transcription factor, the inactivation of which halts cellular apoptosis. In approximately half of all tumours that are malignant, p53 is perminantly disabled or deleted. However, in the other 50% of mutated cells, p53 simply remains inactive the misexpression of MDM2, which interferes with the proper functions of p53 [1]. So the object of the article is that disruption or inhibition of the MDM2-p53 interaction may correct p53 functioning and serve as a form of cancer therapy, such as suppression of tumour growth. Subsequently the problem that the authors tackle with is how to inhibit the actions of MDM2."

More papers on "MDM2 and p53 Signaling in Cancer"

About AcaDemon

We have thousands of high-quality term papers, research papers, essays, book reports and dissertations on every topic. At AcaDemon, you can download those term papers to help you write yours! You can be sure that the term paper, essay, book report or research paper you download are top-quality, competitively priced and high-level work.

*Look for more research papers, essays and book reports on MDM2 and p53 Signaling in Cancer

If you can't find your topic here, try another search

or try our affordable, unique custom paper alternative

Custom Research Services include:

  • Papers written from scratch, according to your specifications.
    Every paper is UNIQUE - Guaranteed
  • Professional, top-notch writers
  • All topics covered
  • Any deadline
  • Your satisfaction guaranteed

Place a Custom Research order now

Find out more about Custom Research



This Free Term Paper Abstract is a part of our Term Paper Library.Here you can purchase research papers, examples of essays, academic dissertations, articles, notes, analytical papers, book reports, stories and poems. We have thousands of persuasive, point-of-view, narrative, critical, compare and contrast and other types of essays in our Library. You can also find here Term papers on "MDM2 and p53 Signaling in Cancer", Essays on "MDM2 and p53 Signaling in Cancer", Research papers on "MDM2 and p53 Signaling in Cancer", Student papers on "MDM2 and p53 Signaling in Cancer", Book reports on "MDM2 and p53 Signaling in Cancer", Dissertation on "MDM2 and p53 Signaling in Cancer", Thesis on "MDM2 and p53 Signaling in Cancer", Summary of paper on "MDM2 and p53 Signaling in Cancer", Articles written on "MDM2 and p53 Signaling in Cancer".

Shopping Cart
 Total :
$ 0.00
Special Offer
Buy one paper and get
40% off the 2nd paper*
 
*The least expensive paper